trending Market Intelligence /marketintelligence/en/news-insights/trending/jfmztxjtmj0yenqvcu6ypg2 content esgSubNav
In This List

HealthEquity releases FY'19 outlook

Podcast

Private Markets 360° | Episode 8: Powering the Global Private Markets (with Adam Kansler of S&P Global Market Intelligence)

Blog

Kensho Launches Word Error Rate Calculator

Blog

Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps

Blog

Bank failures: The importance of liquidity and funding data


HealthEquity releases FY'19 outlook

HealthEquity Inc. released its outlook for fiscal year 2019, as well as its results for its fiscal fourth quarter and fiscal year 2018 .

It expects revenue of between $276.0 million and $282.0 million and net income in the range of $47.0 million to $51.0 million for the fiscal year ending Jan. 31, 2019. HealthEquity projects net income per share of 74 cents to 80 cents.

The company's adjusted EBITDA outlook is a range of $106.0 million to $111.0 million.

Non-GAAP net income is expected to be between $63.0 million and $67.0 million, or between 98 cents and $1.04 per share.

The S&P Capital IQ consensus normalized EPS estimate for 2019 is $1.02.

HealthEquity also reported net income of $5.9 million, or 9 cents per share, in its fiscal fourth quarter, up from $4.1 million, or 7 cents per share, in the prior-year quarter.

The company's non-GAAP net income for its fiscal fourth quarter was $7 million, or 11 cents per share.

The S&P Capital IQ consensus normalized EPS estimate for the fiscal fourth quarter was 9 cents.

For its fiscal year 2018, HealthEquity posted net income of $47.4 million, or 77 cents per share, higher than $26.4 million, or 44 cents per share, a year ago.

Non-GAAP net income for the 2018 fiscal year was $42 million, or 68 cents per share.

The consensus normalized EPS estimate for 2018 was 66 cents, according to S&P Capital IQ.